BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Religare maintains buy on Aurobindo Pharma
Combined with a turnaround in the EU business and cheap valuations, "we expect the stock to re-rate", Religare said.